NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2

This publication has 36 references indexed in Scilit:

• TIPE2 ameliorates neuroinflammation and cognitive impairment in sepsis-associated encephalopathy through regulating RhoA/ROCK2–NF-κB signaling pathway
  Biochemical Pharmacology, 2023
• Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis
  Metabolism, 2023
• Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1
  Cell Metabolism, 2021
• Transthyretin Regulated by linc00657/miR-205-5p Promoted Cholesterol Metabolism by Inducing SREBP2-HMGCR and Inhibiting LXRα-CYP7A1
  Archives of Medical Research, 2020
• LncRNA MEG3 functions as a ceRNA in regulating hepatic lipogenesis by competitively binding to miR-21 with LRP6
  Metabolism, 2019
• The long noncoding RNA NORAD enhances the TGF‐β pathway to promote hepatocellular carcinoma progression by targeting miR‐202‐5p
  Journal of Cellular Physiology, 2018
• Ubiquitin‐Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6
  Hepatology, 2018
• miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries
  The American Journal of Pathology, 2018
• Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
  Cell, 2016
• ROCK2 promotes HCC proliferation by CEBPD inhibition through phospho‐GSK3β/β‐catenin signaling
  FEBS Letters, 2015